Background
Thirty percent of subarachnoid hemorrhage (SAH) patients experience delayed cerebral ischemia (DCI) or delayed ischemic neurological decline (DIND). Variability in the definitions of delayed ischemia make outcome studies difficult to compare. A recent consensus statement advocates standardized definitions for delayed ischemia in clinical trials of SAH. We sought to evaluate the inter-rater agreement (IRA) of these definitions.
Methods
Based on consensus definitions, we assessed for: 1. Delayed cerebral infarction (DCIN), defined as radiographic cerebral infarction; 2. DIND Type 1 (DIND1), defined as focal neurological decline; and 3. DIND2, defined as a global decline in arousal. Five neurologists retrospectively reviewed electronic records of 58 SAH patients. Three reviewers had access to and reviewed neuroradiology imaging. We assessed IRA using Gwet's kappa statistic.
Results
IRA statistics were excellent (95.83%) for overall agreement on the presence or absence of any delayed ischemic event (DIND1, DIND2 or DCIN). Agreement was “moderate” for specifically identifying DIND1 (56.58%) and DIND2 (48.66%) events. We observed greater agreement for DIND1 when there was a significant focal motor decline of at least 1 point in the motor score. There was fair agreement (39.20%) for identifying DCIN; CT imaging was the predominant modality.
Conclusion
Consensus definitions for delayed cerebral ischemia yielded near-perfect overall agreement and can thus be applied in future large scale studies. However, a strict process of adjudication, explicit thresholds for determining focal neurologic decline and MRI techniques that better discriminate edema from infarction appear critical for reproducibility of determination of specific outcome phenotypes, and will be important for successful clinical trials.